Obesity-related nephropathy in children

Pediatric Health

Volumn 3, Issue 2, 2009, Pages 141-153

  Abitbol, Carolyn L ^a   Rodríguez, Maria M ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Fetal programming; Glomerular hyperfiltration; Metabolic syndrome; Microalbuminuna; Nephron mass; Obesity related glomerulosclerosis

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

BARIATRIC SURGERY; CHILD; CREATININE CLEARANCE; FOCAL GLOMERULOSCLEROSIS; GENETIC PREDISPOSITION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY HYPOPLASIA; KIDNEY SCINTISCANNING; LABORATORY TEST; METABOLIC SYNDROME X; MICROALBUMINURIA; NONHUMAN; OBESITY; PATHOGENESIS; PROTEINURIA; REVIEW; WEIGHT REDUCTION;

EID: 70349645685     PISSN: 17455111     EISSN: None     Source Type: Journal    
DOI: 10.2217/phe.09.11     Document Type: Review

References (121)

1. World Health Organization: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ. Tech. Rep. Ser. 894, 1-253 (2000).
2. Hossain P, Kawar B, El Nahas M: Obesity and diabetes in the developing world - a growing challenge. N. Engl. J. Med. 356, 213-215 (2007).
3. Ebbeling CB, Pawlak DB, Ludwig DS: Childhood obesity: public health crisis, common sense cure. Lancet 360, 473-482 (2002).
4. USRDS: The United States renal data system, 2008 annual data report. Am. J. Kidney Dis. 53(Suppl. 1), S23-S36; S297-S308 (2009).
5. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 59, 1498-1509 (2001).
6. Fox CS, Larson MG, Leip EP et al.: Predictors of new-onset kidney disease in a community-based population. JAMA 291, 844-850 (2004).
7. Hsu C, McCulloch CE, Iribarren C et al.: Body mass index and risk for end-stage renal disease. Ann. Intern. Med. 144, 21-28 (2006).
8. Gelber RP, Kurth T, Kausz AT et al.: Association between body mass index and CKD in apparently healthy men. Am. J. Kidney Dis. 46, 871-880 (2005).
9. Bonnet F, Deprele C, Sassolas A et al.: Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am. J. Kidney Dis. 37, 720-727 (2001).
10. Ducloux D, Kazory A, Simula-Faivre D, Chalopin JM: One-year post-transplant weight gain is a risk factor for graft loss. Am. J. Transplant. 5, 2922-2928 (2005).
11. Meier-Kriesche HU, Arndorfer JA, Kaplan B: The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 73, 70-74 (2002).
12. Massarweh NN, Clayton JL, Mangum CA et al.: High body mass index and short-and long-term renal allograft survival in adults. Transplantation 80, 1430-1434 (2005).
13. Brenner BM, Mackenzie HS: Nephron mass as a risk factor for progression of renal disease. Kidney Int. Suppl. 63, S124-S127 (1997).
14. Singh GR, Hoy WE: Kidney volume, blood pressure and albuminuria: findings in an Australian Aboriginal community. Am. J. Kidney Dis. 43, 254-259 (2004).
15. Narva AS: The spectrum of kidney disease in American Indians. Kidney Int. Suppl. 83, 53-57 (2003).
16. Bryson CL, Ross HJ, Boyko EJ, Young BA: Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: Associations with diabetes and level of CKD. Am. J. Kidney Dis. 48, 720-726 (2006).
17. Lackland DT, Bendal HE, Osmond C, Egan BM, Barker DJP: Low birth weight contributes to the high rates of early onset chronic renal failure on the Southeast United States. Arch. Intern. Med. 160, 1472-1476 (2000).
18. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME: Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 298, 564-567 (1989).
19. Bogdarina I, Welham S, King PJ, Burns SP, Clark AJ: Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ. Res. 100(4), 520-526 (2007).
20. Langley-Evans SC, Welham SJ, Jackson AA: Fetal exposure to a maternal low protein diet impairs nephrogenesis and promotes hypertension in the rat. Life Sci. 64, 965-974 (1999).
21. Woods LL, Ingelfinger JR, Nyengaard JR, Rasch R: Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr. Res. 49, 460-467 (2001).
22. Brennan KA, Olson DM, Symonds ME: Maternal nutrient restriction alters renal development and blood pressure regulation of the offspring. Proc. Nutr. Soc. 65, 116-124 (2006).
23. Makrakis J, Zimanyi MA, Black MJ: Retinoic acid enhances nephron endowment in rats exposed to maternal protein restriction. Pediatr. Nephrol. 22(11), 1861-1867 (2007).
24. Gicquel C, El-Osta A, Le Bouc Y: Epigenetic regulation and fetal programming. Best. Pract. Res. Clin. Endocrinol. Metab. 22(1), 1-16 (2008).
25. Ravelli GP, Stein ZA, Susser MW: Obesity in young men after famine exposure in utero and early infancy. N. Engl. J. Med. 295, 349-353 (1976).
26. Vickers MH, Breier BH, McCarthy D, Gluckman PD: Sedentary behavior during postnatal life is determined by prenatal environment and exacerbated by postnatal hypercaloric nutrition. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R271-R273 (2003).
27. Vickers MH, Breier BH, Cutfield WS, Hofman PI, Gluckman PD: Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am. J. Physiol. Endocrinol. Metab. 278, E83-E87 (2000).
28. Cianfarani S Germani D, Branca E: Low birth weight and adult insulin resistance: the 'catch-up growth' hypothesis. Arch. Dis. Child. 81, F71-F73 (1999).
29. Waterland RA: Does nutrition during infancy and early childhood contribute to later obesity via metabolic imprinting of epigenetic gene regulatory mechanisms? In: Feeding During Late Infancy and Early Childhood: Impact on Health. Hernell O, Schmitz J (Eds). Nestec Ltd, Vevey/S Karger AG, Basel, Switzerland 56, 157-174 (2005).
30. Hovi P, Andersson S, Eriksson JG et al.: Glucose regulation in young adults with very low birth weight. N. Engl. J. Med. 356(20), 2053-2063 (2007).
31. Weiss R, Dziura J, Burgert TS et al.: Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med. 350, 2362-2374 (2004).
32. Adelman RD, Restaino JG, Alon US, Blowley DL: Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J. Pediatr. 138, 482-485(2001).
33. Hodgin JB, Rasoulpour M, Markowitz GS, D'Agati VD: Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 4, 71-76 (2009).
34. Simonetti GD, Raio L, Surbek D, Nelle M, Frey FJ, Mohaupt MG: Salt sensitivity of children with low birth weight. Hypertension 52, 625-630 (2008).
35. Irving RJ, Belton NR, Elton RA, Walker BR: Adult cardiovascular risk factors in premature babies. Lancet 355, 2135-2213 (2000)
36. Keijzer-Veen MG, Schrevel M, Finken MJ et al.: Dutch POPS-19 Collaborative Study Group. Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation. J. Am. Soc. Nephrol. 9, 2762-2768 (2005).
37. D'Agati V: Pathologic classification of focal segmental glomerulosclerosis. Sem. Nephrol. 23(2), 117-134 (2003)
38. Haas M, Meehan SM, Karrison TG, Spargo BH: Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am. J. Kidney Dis. 30(5), 621-631 (1997).
39. Yoshikawa N, Ito H, Akamatsu R et al.: Focal segmental glomerulosclerosis with and without nephrotic syndrome in children. J. Pediatr. 109, 65-70 (1986).
40. Srivastava T, Simon SD, Alon US: High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood. Pediatr. Nephrol. 13, 13-18 (1999).
41. Borges FF, Shiraichi L, da Silva MP, Nishimoto EI, Nogueira PC: Is focal segmental glomerulosclerosis increasing in patients with nephrotic syndrome? Pediatr. Nephrol. 22(9), 1309-1313 (2007).
42. Hughson M, Farris AB 3rd, Douglas-Denton R, Hoy WE, Bertram JF: Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int. 63(6), 2113-2122 (2003).
43. Brenner BM, Lawler EV, Mackenzie HS: The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int. 49, 1774-1777 (1996).
44. Hershkovitz D, Burbea Z, Skorecki K, Brenner BM: Fetal programming of adult kidney disease: Cellular and molecular mechanisms (review). Clin. J. Am. Soc. Nephrol. 2, 334-342 (2007).
45. Hoy WE, Douglas-Denton RN, Hughson M, Cass A, Johnson K, Bertram JF: A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int. 63, S31-S37 (2003).
46. Hoy WE, Hughson MD, Douglas-Denton R, Amann K: Nephron number, hypertension, renal disease and renal failure. J. Am. Soc. Nephrol. 16, 2557-2564 (2005).
47. Royer P, Habib R, Mathieu H, Coutecuisse V: L'hypolasie rénale bilaterale congénitale avec réduction du nombre et hypertrophie des néphrons chez l'enfant. Annales de Pédiatrie 9, 133-140 (1962).
48. Royer P, Habib R, Courtecuisse V, Leclerc F: Bilateral renal hypoplasia with oligonephronia. (Study of 21 cases) Arch. Fr. Pediatr. 24(3), 249-268 (1967).
49. Rodriguez MM: Developmental renal pathology: its past, present, and future. Fetal. Pediatr. Pathol. 23(4), 211-229 (2004).
50. Weisinger JR, Kempson RL, Eldridge FL, Swenson RS: The nephrotic syndrome: a complication of massive obesity. Ann. Intern. Med. 81, 440-447 (1974).
51. Cohen AH: Massive obesity and the kidney. Am. J. Pathol. 81, 117-130 (1975).
52. D'Agati V: The many masks of focal segmental glomerulosclerosis. Kidney Int. 46, 1223-1241 (1994).
53. Schwimmer JA, Markowitz GS, Valeri AM, Imbriano LJ, Alvis R, D'Agati VD: Secondary focal segmental glomerulosclerosis in non-obese patients with increased muscle mass. Clin. Nephrol. 60(4), 233-241 (2003).
54. Praga M, Hernández E, Herrero JC et al.: Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 58, 2111-2118 (2000)
55. Praga M, Hernández E, Morales E et al.: Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 16(9), 1790-1798 (2001).
56. Kiprov DD, Colvin RB, McCluskey AB: Focal and segmental glomerulosclerosis and proteinuria associated with unilateral renal agenesis. Lab. Invest. 46, 275-281 (1982).
57. Lent V, Harth J: Nephropathy in remnant kidneys: Pathological proteinuria after unilateral nephrectomy. J. Urol. 152, 312-316 (1994).
58. Argueso LR, Ritchey ML, Boyle ET, Milliner DS, Bergstralh EJ, Kramer SA: Prognosis of patients with unilateral agenesis. Pediatr. Nephrol. 6, 412-416 (1992).
59. Argueso LR, Ritchey ML, Boyle ET, Milliner DS, Bergstralh EJ, Kramer SA: Prognosis of children with solitary kidney after unilateral nephrectomy. J. Urol. 148, 747-751 (1992).
60. Shah MM, Sampogna RV, Sakurai H, Bush KT, Nigam SK: Branching morphogenesis and kidney disease. Development 131(7), 1449-1462 (2004).
61. Anderson S, Brenner BM: Effects of aging on the renal glomerulus. Am. J. Med. 80, 435-442 (1986).
62. Nyengaard JR, Bendtsen TF: Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat. Rec. 232, 194-201 (1992).
63. Merlet-Bénichou C, Gilbert T, Vilar J, Moreau E, Freund N, Lelièvre-Pégorier M: Nephron number: variability is the rule. Causes and consequences. Lab. Invest. 79, 515-527 (1999).
64. Rodríguez MM, Gómez AH, Abitbol CL, Chandar JJ, Duara S, Zilleruelo GE: Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr. Dev. Pathol. 7, 17-25 (2004).
65. Keller G, Zimmer G, Mall G, Ritz E, Amann K: Nephron number in patients with primary hypertension. N. Engl. J. Med. 348, 101-108 (2003).
66. Hoy WE, Hughson MD, Singh GR, Douglas-Denton R, Bertram JF: Reduced nephron number and glomerulomegaly in Australian Aborigines: a group at high risk for renal disease and hypertension. Kidney Int. 70, 104-110 (2006).
67. Mañalich R, Reyes L, Herrera M, Melendi C, Fundora I: Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int. 58, 770-773 (2000).
68. Regan FM, Cut?eld WS, Jefferies C, Robinson E, Hofman PL: The impact of early nutrition in premature infants on later childhood insulin sensitivity and growth. Pediatrics 118(5), 1943-1949 (2006).
69. Jimenez-Chillaron JC, Patti ME: To catch up or not to catch up: is this the question? Lessons from animal models. Curr. Opin Endocrinol. Diabetes Obes. 14(1), 23-29 (2007).
70. Lucas A: Programming by early nutrition: an experimental approach. J. Nutr. 128, 401S-406S (1998).
71. Singhal A, Farooqi IS, O'Rahilly S, Lucas A: Early nutrition and leptin concentrations in later life. Am. J. Clin. Nutr. 75, 993-999 (2002).
72. Abitbol CL, Bauer CR, Montané B, Chandar J, Duara S, Zilleruelo G: Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr. Nephrol. 18(9), 887-893 (2003).
73. Vikse BE, Irgens LM, Leivestad T, Hallan S, Iversen BM: Low birth weight increases risk for end stage renal disease. J. Am. Soc. Nephrol. 19, 151-157 (2008).
74. Simonetti GD, Raio L, Surbek D, Nelle M, Frey FJ, Mohaupt MG: Salt sensitivity of children with low birth weight. Hypertension. 52, 625-630 (2008).
75. Rosenblum ND: Developmental biology of the human kidney. Semin. Fetal Neonatal. Med. 13, 125-132 (2008).
76. Pohl M, Stuart RO, Sakurai H, Nigam SK: Branching morphogenesis during kidney development. Ann. Rev. Physiol. 62, 595-620 (2000).
77. Hinchliffe SA, Sargent PH, Chan YF et al.: 'Medullary ray glomerular counting' as a method of assessment of human nephrogenesis. Pathol. Res. Pract. 188, 775-782 (1992).
78. Chen YW, Tran S, Chenier I et al.: Deficiency of intrarenal angiotensin II type 2 receptor impairs paired homeo box-2 and N-myc expression during nephrogenesis. Pediatr. Nephrol. 23(10), 1769-1777 (2008).
79. Sequeira Lopez ML, Gomez RA: The role of angiotensin II in kidney embryogenesis and kidney abnormalities. Curr. Opin Nephrol. Hypertens. 13, 117-122 (2004).
80. Salomon R, Tellier AL, Attie-Bitach T et al.: PAX2 mutations in oligomeganephronia. Kidney Int. 59, 457-462 (2001).
81. Quinlan J, Lemire M, Hudson T et al.: A common variant of the PAX2 gene is associated with reduced newborn kidney size. J. Am. Soc. Nephrol. 18, 1915-1921 (2007).
82. Lewis RM, Forhead AJ, Petry CJ, Ozanne SE, Hales CN: Long-term programming of blood pressure by maternal dietary iron restriction in the rat. Br. J. Nutr. 88, 283-290 (2002).
83. Lelièvre-Pégorier M, Vilar J, Ferrier ML et al.: Mild vitamin A deficiency leads to inborn nephron deficit in the rat. Kidney Int. 54, 1455-1462 (1998).
84. Ortiz LA, Quan A, Weinberg A, Baum M: Effect of prenatal dexamethasone on rat renal development. Kidney Int. 59, 1663-1669 (2001).
85. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH: Establishing a standard de?nition for child overweight and obesity: International survey. BMJ 320, 1240-1243 (2000).
86. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS: Risk factors and adult body mass index among overweight children: the Bogalusa Heart study. Pediatrics 123(3), 750-757 (2009).
87. Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548-2556 (2004).
88. Wahba IM, Mak RH: Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2, 550-562 (2007).
89. Weiss R, Dziura J, Burgert TS et al.: Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med. 350, 2362-2374 (2004).
90. Reaven GM: Pathophysiology of insulin resistance in human disease. Physiol. Rev. 75(3), 473-486 (1995).
91. Grundy SM, Cleeman JI, Merz CN et al.; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110(2), 227-239 (2004). Erratum in: Circulation 110(6), 763 (2004).
92. Chen J, Muntner P, Hamm LL et al.: The metabolic syndrome and chronic kidney disease in U.S. adults. Ann. Intern. Med. 140(3), 167-174 (2004).
93. Lee S, Bacha F, Gungor N, Arslanian S: Comparisons of different definitions of pediatric metabolic syndrome: relation to abdominal obesity, insulin resistance, adiponectin, and inflammatory biomarkers. J. Pediatr. 152, 177-184 (2008).
94. Zimmet P, Alberti K, George MM et al.: IDF Consensus Group: the metabolic syndrome in children and adolescents - an IDF consensus report. Pediatric Diabetes 8, 299-306 (2007).
95. Abitbol CL, Chandar J, Rodriguez MM et al.: Obesity and preterm birth: additive risks in the progression of kidney disease in children. Pediatr. Nephrol. DOI:10.1007/s00467-009-1120-1122 (2009) (Epub ahead of print).
96. Tomaszewski M, Charchar FJ, Maric C et al.: Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int. 71, 816-821 (2007).
97. Rosenbaum DM, Korngold E, Teele RL: Sonographic assessment of renal length in normal children. Am. J. Radiol. 142, 467-469 (1983).
98. Dinkel E, Ertel M, Dittrich M, Peters H, Berres M, Schulte-Wissermann H: Kidney size in childhood: sonographic growth charts for kidney length and volume. Pediatr. Radiol. 15, 38-43 (1985).
99. Sfakianakis GN, Sfakianaki E: Renal scintigraphy in children. Urology 57(6), 1167-1177 (2001).
100. Barbari A, Stephan A, Masri MA et al.: Nephron mass in kidney transplantation. Transplant Proc. 34, 2401-2402 (2002).
101. Tan JC, Workeneh B, Busque S, Blouch K, Derby G, Myers BD: Glomerular function, structure, and number in renal allografts from older deceased donors. J. Am. Soc. Nephrol. DOI:10.1681/ASN.2008030306 (2009) (Epub ahead of print).
102. Schwartz GJ, Furth S, Cole SR, Warady B, Munoz A: Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children. Kidney Int. 69, 2070 -2077 (2006).
103. Schwartz GJ, Muñoz A, Schneider MF et al.: New equations to estimate GFR in children with CKD. J. Am. Soc. Nephrol. 20(3), 629-637 (2009).
104. Agarwal R, Bills JE, Yigazu PM et al.: Assessment of iothalamate plasma clearance: duration of study affects quality of GFR. Clin. J. Am. Soc. Nephrol. 4, 77-85 (2009)
105. Schwartz GJ, Brion LP, Spitzer A: The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr. Clin. North Am. 34, 571-590 (1987).
106. Filler G, Lepage N: Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr. Nephrol. 18, 981-985 (2003).
107. Groesbeck D, Köttgen A, Parekh R et al.: Age, gender, and race effects on cystatin C levels in US adolescents. Clin. J. Am. Soc. Nephrol. 3, 1777-1785 (2008).
108. Hogg RJ, Portman RJ, Milliner D, Lemley KV, Eddy A, Ingelfinger J: Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk Assessment, Detection and Elimination (PARADE). Pediatrics 105(6), 1242-1249 (2000).
109. Abitbol CL, Chandar J, Onder AM, Nwobi O, Montane B, Zilleruelo G: Profiling proteinuria in pediatric patients. Pediatr. Nephrol. 21 (7), 995-1002 (2006).
110. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C: Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity index for assessing insulin resistance among obese children and adolescents. Pediatrics 115, E500-E503 (2005).
111. Chandar J, Abitbol C, Montané B, Zilleruelo G: Angiotensin blockade as sole treatment for proteinuric kidney disease in children. Nephrol. Dial. Transplant. 22(5), 1332-1337 (2007).
112. de Paula RB, da Silva AA, Hall JE: Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension 43, 41-47 (2004)
113. Ding SS, Qiu C, Hess P, Xi JF, Zheng N, Clozel M: Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat. J. Cardiovasc. Pharmacol. 42(1), 48-54 (2003).
114. Bosch J, Lonn E, Pogue J, Arnold JM, Dagenais GR, Yusuf S; HOPE/HOPE-TOO Study Investigators. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension. Circulation 112(9), 1339-1346 (2005).
115. Mann JF, Schmieder RE, McQueen M et al.; ONTARGET investigators: Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372(9638), 547-553 (2008).
116. Fujihara CK, Noronha IL, Malheiros, Antunes GR, de Oliveira IB, Zatz R: Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney. J. Am. Soc. Nephrol. 11(2), 283-290 (2000).
117. Rodríguez-Iturbe B, Quiroz Y, Shahkarami A, Li Z, Vaziri ND: Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rat. Kidney Int. 68(3), 1041-1047 (2005).
118. Kelishadi R, Hashemi M, Mohammadifard N, Asgary S, Khavarian N: Association of changes in oxidative and proinflammatory states with changes in vascular function after a lifestyle modification trial among obese children. Clin. Chem. 54(1), 147-153 (2008).
119. Fowler SM, Kon V, Ma L, Richards WO, Fogo AB, Hunley TE: Obesity-related focal and segmental glomerulosclerosis: normalization of proteinuria in an adolescent after bariatric surgery. Pediatr. Nephrol. 24, 851-855 (2009).
120. Lawson ML, Kirk S, Mitchell T et al.; Pediatric Bariatric Study Group: One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group. J. Pediatr. Surg. 41, 137-143; discussion 137-143 (2006).
121. Shield JPH, Crowne E, Morgan J: Is there a place for bariatric surgery in treating childhood obesity? Arch. Dis. Child. 93, 369-372 (2008).